Citeline Podcasts

Pink Sheet reporters and editor discuss differing views of coronavirus vaccine approval plans from Operation Warp Speed and the FDA, Commissioner Hahn encouraging providers to be confident in agency-approved vaccines and therapeutics, and a study of internal disagreements in FDA drug assessments.

In this week's edition of the Device Week podcast, Medtech Insight managing editor discusses the rapid growth of telehealth services for mental health and Catherine Longworth explains Thermo Fisher is dropping plans to acquire Qiagen.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

Opportunities For Medtech In Mental Health

Qiagen Terminates Thermo Fisher Deal After Shareholders Reject Last Offer

Hedge Fund Seeks Higher Price For Qiagen As COVID-19 Boosts Sales

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

Pink Sheet reporters and editors dig into the emerging coronavirus vaccine regulatory schedule, look at vaccine purchasing trends, and consider the curious case of a federal government billboard encouraging convalescent plasma donations.

In this Device Week, Ashley Yeo asks PB Consulting managing director Dan Jones about the adjustments needed by UK medtechs as they face a confluence of change brought about by Brexit, COVID-19 and NHS reform, at time when the MHRA has come under increased scrutiny.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

On this week’s podcast we talk about a new study that says medical products companies that include women on their board of directors recall the most problematic of goods weeks faster.

Medtech Insight articles addressing topics discussed in this episode:

• Want To Make Faster Class I Recall Decisions? Then Put Women In The Boardroom, Study Says

Pink Sheet reporters and editor discuss the start of Phase III coronavirus vaccine trials, FDA’s pandemic work moving away from the idea stage, and the push for a permanent extension of the rare pediatric disease priority review voucher program.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

Pink Sheet reporters and editors discuss the performance of the leaders of several coronavirus vaccine manufacturers during a recent congressional hearing and discuss proposed changes to the generic and prescription drug user fee programs.